CPHI Milan newsletter
PCI High Potent Manufacturing
LB Bohle – 10.06.2025
Temax_Krautz

Current Edition

Current Edition

CDMO Subsection

Insights into the latest developments in CDMO services and manufacturing.

Continue reading

Injectables Subsection

Expert perspectives on the evolving needs of injectable therapies and packaging.

Continue reading

Nasal & Pulmonary Subsection

Exploring the latest developments in inhalation technologies, respiratory delivery and sustainability

Continue reading

Advertisement

CPHI Milan
DDL 2026

Advertisement

Nipro August 26

Advertisement

Merxin March 2026

Advertisement

Lifecore Biomedical

Advertisement

Solstice
Volume 15 Issue 4

Ophthalmic Drug Delivery for Patients

IPI speaks with Yuki Takeuchi on requirements and trends in ophthalmic drug delivery, and Terumo's solutions in the segment focusing on their primary container platf...
Continue Reading →
Volume 15 Issue 4

Understanding and Working Towards Container Closure Integrity

Primum non nocere. First, do no harm. This sentence, often considered as the official motto of healthcare providers, organisations, and associations around the wo...
Continue Reading →
Volume 15 Issue 3

Keeping eCOAs Off the Critical Path – Key Considerations

The prevalence of decentralised clinical trials, rising demand for preventive healthcare solutions, a market driven by the need for more and better-quality data and ...
Continue Reading →
Volume 15 Issue 3

Taking Healthcare Out of the Hospital: How Device Design Can Empower Users

From point-of-care diagnostics to auto-injectors, medical devices are increasingly enabling more procedures and healthcare activities to be conducted outside of the ...
Continue Reading →
Volume 15 Issue 2

Individual Device Identification: Coding and Marking for the New Dimension in Patient Health and Safety

Counterfeit products and product piracy are serious issues for the pharmaceutical industry – but recent product marking requirements in developed economies, includin...
Continue Reading →
Volume 15 Issue 2

Net Zero Healthcare – Priorities for Decarbonising the Pharma Supply Chain

The climate and our health are inextricably linked. The effects of climate change on global health systems and outcomes are already clear, with WHO proclaiming it to...
Continue Reading →
Volume 15 Issue 2

Harnessing the Power of cMaaS in Pharma Logistics

Ensuring Regulatory Compliance and Sustainable Supply Chain Management End-to-end digital visibility across the supply chain can be used to identify hotspots, sup...
Continue Reading →
Volume 15 Issue 1

Intellectual Property Matters for Economic, Social, Technological, Scientific, and Industrial Development

Q: SPL – Please tell us about ARIPO. Why was ARIPO formed and what are your core functions and visions of ARIPO? A: The African Regional Intellectual Property Org...
Continue Reading →
Volume 15 Issue 1

How Are Emerging Biotechs Harnessing Strategic Partnerships to Strengthen Their Journey to Commercialisation?

Forecasted to reach $108 billion by 2023, the global pharmaceutical services outsourcing market is currently undergoing incredible levels of growth. Organisations...
Continue Reading →
Volume 15 Issue 1

Navigating the Data-driven Future of Life Sciences Regulatory Processes: Who Will Take the Lead?

Generis hosted a live video discussion with a panel of industry thought leaders from BioNTech, Bayer, Iperion – a Deloitte business, and Beczek. COM to discuss the c...
Continue Reading →

Advertisement

MedPharm 16/07

Advertisement

Biopharma group march 2026

Advertisement

Silgan March 2026

Advertisement

Terumo 06/26

Advertisement

Scott Pharma – 25.03.2025

Advertisement

Bespak

Advertisement

Tjoapack
Aptar – 08/01/2026